A detailed history of Pro Share Advisors LLC transactions in Mannkind Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 66,357 shares of MNKD stock, worth $465,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,357
Previous 51,745 28.24%
Holding current value
$465,826
Previous $270,000 54.07%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.01 - $6.7 $73,206 - $97,900
14,612 Added 28.24%
66,357 $416,000
Q2 2024

Aug 13, 2024

SELL
$4.05 - $5.43 $56,967 - $76,378
-14,066 Reduced 21.37%
51,745 $270,000
Q1 2024

May 08, 2024

BUY
$3.25 - $5.27 $17,602 - $28,542
5,416 Added 8.97%
65,811 $298,000
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $31,686 - $40,699
9,487 Added 18.64%
60,395 $219,000
Q3 2023

Nov 13, 2023

BUY
$3.91 - $5.45 $1,575 - $2,196
403 Added 0.8%
50,908 $210,000
Q2 2023

Aug 10, 2023

BUY
$3.72 - $4.79 $8,358 - $10,763
2,247 Added 4.66%
50,505 $205,000
Q1 2023

May 11, 2023

SELL
$3.95 - $5.63 $24,746 - $35,271
-6,265 Reduced 11.49%
48,258 $197,000
Q4 2022

Feb 02, 2023

BUY
$3.02 - $5.37 $16,425 - $29,207
5,439 Added 11.08%
54,523 $287,000
Q3 2022

Nov 04, 2022

BUY
$2.99 - $4.35 $4,347 - $6,324
1,454 Added 3.05%
49,084 $152,000
Q2 2022

Aug 01, 2022

SELL
$2.67 - $4.77 $66,018 - $117,943
-24,726 Reduced 34.17%
47,630 $181,000
Q1 2022

May 10, 2022

SELL
$2.62 - $4.45 $44,458 - $75,512
-16,969 Reduced 19.0%
72,356 $267,000
Q4 2021

Feb 08, 2022

BUY
$4.05 - $5.37 $17,605 - $23,343
4,347 Added 5.12%
89,325 $391,000
Q3 2021

Nov 12, 2021

SELL
$3.89 - $5.48 $92,760 - $130,676
-23,846 Reduced 21.91%
84,978 $370,000
Q2 2021

Aug 13, 2021

BUY
$3.61 - $5.45 $50,431 - $76,136
13,970 Added 14.73%
108,824 $593,000
Q1 2021

May 14, 2021

BUY
$3.14 - $6.14 $29,591 - $57,863
9,424 Added 11.03%
94,854 $372,000
Q4 2020

Feb 09, 2021

BUY
$1.79 - $4.04 $38,479 - $86,847
21,497 Added 33.62%
85,430 $267,000
Q3 2020

Nov 13, 2020

BUY
$1.56 - $2.08 $1,478 - $1,971
948 Added 1.51%
63,933 $120,000
Q2 2020

Aug 03, 2020

BUY
$0.94 - $2.21 $22,185 - $52,160
23,602 Added 59.93%
62,985 $110,000
Q1 2020

May 15, 2020

SELL
$0.84 - $1.76 $25,762 - $53,979
-30,670 Reduced 43.78%
39,383 $41,000
Q4 2019

Feb 12, 2020

SELL
$1.14 - $1.49 $3,005 - $3,927
-2,636 Reduced 3.63%
70,053 $90,000
Q3 2019

Nov 12, 2019

BUY
$1.04 - $1.44 $593 - $822
571 Added 0.79%
72,689 $91,000
Q2 2019

Aug 13, 2019

SELL
$1.09 - $1.88 $10,121 - $17,457
-9,286 Reduced 11.41%
72,118 $83,000
Q1 2019

May 15, 2019

BUY
$1.14 - $2.25 $14,308 - $28,239
12,551 Added 18.23%
81,404 $160,000
Q4 2018

Feb 14, 2019

SELL
$1.02 - $2.05 $10,883 - $21,873
-10,670 Reduced 13.42%
68,853 $73,000
Q3 2018

Nov 14, 2018

BUY
$1.01 - $2.19 $2,250 - $4,879
2,228 Added 2.88%
79,523 $146,000
Q2 2018

Aug 13, 2018

BUY
$1.59 - $2.38 $34,337 - $51,398
21,596 Added 38.77%
77,295 $147,000
Q1 2018

May 14, 2018

SELL
$2.28 - $3.8 $16,903 - $28,173
-7,414 Reduced 11.75%
55,699 $127,000
Q4 2017

Feb 14, 2018

BUY
$2.28 - $6.71 $143,897 - $423,488
63,113
63,113 $146,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.